Viewing Study NCT02302157

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2026-02-24 @ 8:51 AM
Study NCT ID: NCT02302157
Status: COMPLETED
Last Update Posted: 2021-07-14
First Post: 2014-11-24
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
Sponsor: Lineage Cell Therapeutics, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cervical Spinal Cord Injury View
None Spine Injury View
None Spinal Cord Trauma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cervical spinal cord injury View
None AST-OPC1 View
None SCiStar View
None OPC1 View
None Neural cell View
None Trauma spinal cord View
None stemcell transplant View
None Cervical spine injury View
None Paralysis View
None Quadriplegia View
None Tetraplegia View
None Spine injury View
None oligodendrocyte progenitor cell View
None Subacute spinal cord injury View